Industry Research Reports

Home > Reports > Medical Care > Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 110 Pages

Report ld: 2332812

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.

The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1234 million in 2023 and is forecast to a readjusted size of US$ 1571.4 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

Vertebroplasty & Kyphoplasty Market Size

M= millions and B=billions

Global Vertebroplasty and Kyphoplasty Devices key players include Medtronic, Stryker, J&J (Depuy Synthes), Globus Medical, Merit Medical, etc. Global top five manufacturers hold a share about 85%. North America is the largest market, with a share about 55%, followed by Asia-Pacific, with a share about 25 percent. In terms of product, Kyphoplasty is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Ambulatory Surgery Center, etc.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Vertebroplasty & Kyphoplasty, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Vertebroplasty & Kyphoplasty by region & country, by Type, and by Application.

The Vertebroplasty & Kyphoplasty market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vertebroplasty & Kyphoplasty.

Market Segmentation

Report Metric
Details
Report Title
Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1571.4 million
CAGR(2024-2030)
3.4%
Market Size Available for Years
2019-2030
Global Vertebroplasty & Kyphoplasty Companies Covered
Depuy Synthes, Stryker Corporation, CareFusion Corporation, Osseon LLC., Alphatec Spine, Inc., TAEYEON MEDICAL Co., Ltd., G-21 S.R.L, BMK Global Medical Company, Medtronic, Inc.,, Globus Medical, Inc, SOMATEX
Global Vertebroplasty & Kyphoplasty Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vertebroplasty & Kyphoplasty Market, Segment by Type
Vertebroplastic Device

Kyphoplastic Device
Global Vertebroplasty & Kyphoplasty Market, Segment by Application
Hospitals

Clinics

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vertebroplasty & Kyphoplasty manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Vertebroplasty & Kyphoplasty in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Vertebroplasty & Kyphoplasty in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Vertebroplasty & Kyphoplasty Product Introduction
    1.2 Global Vertebroplasty & Kyphoplasty Market Size Forecast
    1.3 Vertebroplasty & Kyphoplasty Market Trends & Drivers
        1.3.1 Vertebroplasty & Kyphoplasty Industry Trends
        1.3.2 Vertebroplasty & Kyphoplasty Market Drivers & Opportunity
        1.3.3 Vertebroplasty & Kyphoplasty Market Challenges
        1.3.4 Vertebroplasty & Kyphoplasty Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Vertebroplasty & Kyphoplasty Players Revenue Ranking (2023)
    2.2 Global Vertebroplasty & Kyphoplasty Revenue by Company (2019-2024)
    2.3 Key Companies Vertebroplasty & Kyphoplasty Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Vertebroplasty & Kyphoplasty Product Offered
    2.5 Key Companies Time to Begin Mass Production of Vertebroplasty & Kyphoplasty
    2.6 Vertebroplasty & Kyphoplasty Market Competitive Analysis
        2.6.1 Vertebroplasty & Kyphoplasty Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Vertebroplasty & Kyphoplasty Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vertebroplasty & Kyphoplasty as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Vertebroplastic Device
        3.1.2 Kyphoplastic Device
    3.2 Global Vertebroplasty & Kyphoplasty Sales Value by Type
        3.2.1 Global Vertebroplasty & Kyphoplasty Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Vertebroplasty & Kyphoplasty Sales Value, by Type (2019-2030)
        3.2.3 Global Vertebroplasty & Kyphoplasty Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Others
    4.2 Global Vertebroplasty & Kyphoplasty Sales Value by Application
        4.2.1 Global Vertebroplasty & Kyphoplasty Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Vertebroplasty & Kyphoplasty Sales Value, by Application (2019-2030)
        4.2.3 Global Vertebroplasty & Kyphoplasty Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Vertebroplasty & Kyphoplasty Sales Value by Region
        5.1.1 Global Vertebroplasty & Kyphoplasty Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Vertebroplasty & Kyphoplasty Sales Value by Region (2019-2024)
        5.1.3 Global Vertebroplasty & Kyphoplasty Sales Value by Region (2025-2030)
        5.1.4 Global Vertebroplasty & Kyphoplasty Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        5.2.2 North America Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        5.3.2 Europe Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        5.4.2 Asia Pacific Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        5.5.2 South America Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        5.6.2 Middle East & Africa Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value
    6.3 United States
        6.3.1 United States Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        6.3.2 United States Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Vertebroplasty & Kyphoplasty Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        6.4.2 Europe Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Vertebroplasty & Kyphoplasty Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        6.5.2 China Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Vertebroplasty & Kyphoplasty Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        6.6.2 Japan Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Vertebroplasty & Kyphoplasty Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        6.7.2 South Korea Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Vertebroplasty & Kyphoplasty Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        6.8.2 Southeast Asia Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Vertebroplasty & Kyphoplasty Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Vertebroplasty & Kyphoplasty Sales Value, 2019-2030
        6.9.2 India Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Vertebroplasty & Kyphoplasty Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Depuy Synthes
        7.1.1 Depuy Synthes Profile
        7.1.2 Depuy Synthes Main Business
        7.1.3 Depuy Synthes Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.1.4 Depuy Synthes Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.1.5 Depuy Synthes Recent Developments
    7.2 Stryker Corporation
        7.2.1 Stryker Corporation Profile
        7.2.2 Stryker Corporation Main Business
        7.2.3 Stryker Corporation Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.2.4 Stryker Corporation Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.2.5 Stryker Corporation Recent Developments
    7.3 CareFusion Corporation
        7.3.1 CareFusion Corporation Profile
        7.3.2 CareFusion Corporation Main Business
        7.3.3 CareFusion Corporation Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.3.4 CareFusion Corporation Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.3.5 Osseon LLC. Recent Developments
    7.4 Osseon LLC.
        7.4.1 Osseon LLC. Profile
        7.4.2 Osseon LLC. Main Business
        7.4.3 Osseon LLC. Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.4.4 Osseon LLC. Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.4.5 Osseon LLC. Recent Developments
    7.5 Alphatec Spine, Inc.
        7.5.1 Alphatec Spine, Inc. Profile
        7.5.2 Alphatec Spine, Inc. Main Business
        7.5.3 Alphatec Spine, Inc. Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.5.4 Alphatec Spine, Inc. Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.5.5 Alphatec Spine, Inc. Recent Developments
    7.6 TAEYEON MEDICAL Co., Ltd.
        7.6.1 TAEYEON MEDICAL Co., Ltd. Profile
        7.6.2 TAEYEON MEDICAL Co., Ltd. Main Business
        7.6.3 TAEYEON MEDICAL Co., Ltd. Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.6.4 TAEYEON MEDICAL Co., Ltd. Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.6.5 TAEYEON MEDICAL Co., Ltd. Recent Developments
    7.7 G-21 S.R.L
        7.7.1 G-21 S.R.L Profile
        7.7.2 G-21 S.R.L Main Business
        7.7.3 G-21 S.R.L Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.7.4 G-21 S.R.L Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.7.5 G-21 S.R.L Recent Developments
    7.8 BMK Global Medical Company
        7.8.1 BMK Global Medical Company Profile
        7.8.2 BMK Global Medical Company Main Business
        7.8.3 BMK Global Medical Company Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.8.4 BMK Global Medical Company Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.8.5 BMK Global Medical Company Recent Developments
    7.9 Medtronic, Inc.,
        7.9.1 Medtronic, Inc., Profile
        7.9.2 Medtronic, Inc., Main Business
        7.9.3 Medtronic, Inc., Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.9.4 Medtronic, Inc., Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.9.5 Medtronic, Inc., Recent Developments
    7.10 Globus Medical, Inc
        7.10.1 Globus Medical, Inc Profile
        7.10.2 Globus Medical, Inc Main Business
        7.10.3 Globus Medical, Inc Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.10.4 Globus Medical, Inc Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.10.5 Globus Medical, Inc Recent Developments
    7.11 SOMATEX
        7.11.1 SOMATEX Profile
        7.11.2 SOMATEX Main Business
        7.11.3 SOMATEX Vertebroplasty & Kyphoplasty Products, Services and Solutions
        7.11.4 SOMATEX Vertebroplasty & Kyphoplasty Revenue (US$ Million) & (2019-2024)
        7.11.5 SOMATEX Recent Developments

 8 Industry Chain Analysis
    8.1 Vertebroplasty & Kyphoplasty Industrial Chain
    8.2 Vertebroplasty & Kyphoplasty Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Vertebroplasty & Kyphoplasty Sales Model
        8.5.2 Sales Channel
        8.5.3 Vertebroplasty & Kyphoplasty Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Vertebroplasty & Kyphoplasty Market Trends
    Table 2. Vertebroplasty & Kyphoplasty Market Drivers & Opportunity
    Table 3. Vertebroplasty & Kyphoplasty Market Challenges
    Table 4. Vertebroplasty & Kyphoplasty Market Restraints
    Table 5. Global Vertebroplasty & Kyphoplasty Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Vertebroplasty & Kyphoplasty Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Vertebroplasty & Kyphoplasty Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Vertebroplasty & Kyphoplasty Product Type
    Table 9. Key Companies Time to Begin Mass Production of Vertebroplasty & Kyphoplasty
    Table 10. Global Vertebroplasty & Kyphoplasty Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vertebroplasty & Kyphoplasty as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Vertebroplasty & Kyphoplasty Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Vertebroplasty & Kyphoplasty Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Vertebroplasty & Kyphoplasty Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Vertebroplasty & Kyphoplasty Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Vertebroplasty & Kyphoplasty Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Vertebroplasty & Kyphoplasty Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Vertebroplasty & Kyphoplasty Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Vertebroplasty & Kyphoplasty Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Vertebroplasty & Kyphoplasty Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Vertebroplasty & Kyphoplasty Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Vertebroplasty & Kyphoplasty Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Vertebroplasty & Kyphoplasty Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Vertebroplasty & Kyphoplasty Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Vertebroplasty & Kyphoplasty Sales Value by Region (2019-2024) & (%)
    Table 27. Global Vertebroplasty & Kyphoplasty Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value, (2025-2030) & (US$ Million)
    Table 31. Depuy Synthes Basic Information List
    Table 32. Depuy Synthes Description and Business Overview
    Table 33. Depuy Synthes Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Depuy Synthes (2019-2024)
    Table 35. Depuy Synthes Recent Developments
    Table 36. Stryker Corporation Basic Information List
    Table 37. Stryker Corporation Description and Business Overview
    Table 38. Stryker Corporation Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Stryker Corporation (2019-2024)
    Table 40. Stryker Corporation Recent Developments
    Table 41. CareFusion Corporation Basic Information List
    Table 42. CareFusion Corporation Description and Business Overview
    Table 43. CareFusion Corporation Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of CareFusion Corporation (2019-2024)
    Table 45. CareFusion Corporation Recent Developments
    Table 46. Osseon LLC. Basic Information List
    Table 47. Osseon LLC. Description and Business Overview
    Table 48. Osseon LLC. Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Osseon LLC. (2019-2024)
    Table 50. Osseon LLC. Recent Developments
    Table 51. Alphatec Spine, Inc. Basic Information List
    Table 52. Alphatec Spine, Inc. Description and Business Overview
    Table 53. Alphatec Spine, Inc. Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Alphatec Spine, Inc. (2019-2024)
    Table 55. Alphatec Spine, Inc. Recent Developments
    Table 56. TAEYEON MEDICAL Co., Ltd. Basic Information List
    Table 57. TAEYEON MEDICAL Co., Ltd. Description and Business Overview
    Table 58. TAEYEON MEDICAL Co., Ltd. Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of TAEYEON MEDICAL Co., Ltd. (2019-2024)
    Table 60. TAEYEON MEDICAL Co., Ltd. Recent Developments
    Table 61. G-21 S.R.L Basic Information List
    Table 62. G-21 S.R.L Description and Business Overview
    Table 63. G-21 S.R.L Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of G-21 S.R.L (2019-2024)
    Table 65. G-21 S.R.L Recent Developments
    Table 66. BMK Global Medical Company Basic Information List
    Table 67. BMK Global Medical Company Description and Business Overview
    Table 68. BMK Global Medical Company Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of BMK Global Medical Company (2019-2024)
    Table 70. BMK Global Medical Company Recent Developments
    Table 71. Medtronic, Inc., Basic Information List
    Table 72. Medtronic, Inc., Description and Business Overview
    Table 73. Medtronic, Inc., Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Medtronic, Inc., (2019-2024)
    Table 75. Medtronic, Inc., Recent Developments
    Table 76. Globus Medical, Inc Basic Information List
    Table 77. Globus Medical, Inc Description and Business Overview
    Table 78. Globus Medical, Inc Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Globus Medical, Inc (2019-2024)
    Table 80. Globus Medical, Inc Recent Developments
    Table 81. SOMATEX Basic Information List
    Table 82. SOMATEX Description and Business Overview
    Table 83. SOMATEX Vertebroplasty & Kyphoplasty Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of SOMATEX (2019-2024)
    Table 85. SOMATEX Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Vertebroplasty & Kyphoplasty Downstream Customers
    Table 89. Vertebroplasty & Kyphoplasty Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Vertebroplasty & Kyphoplasty Product Picture
    Figure 2. Global Vertebroplasty & Kyphoplasty Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Vertebroplasty & Kyphoplasty Sales Value (2019-2030) & (US$ Million)
    Figure 4. Vertebroplasty & Kyphoplasty Report Years Considered
    Figure 5. Global Vertebroplasty & Kyphoplasty Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Vertebroplasty & Kyphoplasty Revenue in 2023
    Figure 7. Vertebroplasty & Kyphoplasty Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Vertebroplastic Device Picture
    Figure 9. Kyphoplastic Device Picture
    Figure 10. Global Vertebroplasty & Kyphoplasty Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Vertebroplasty & Kyphoplasty Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospitals
    Figure 13. Product Picture of Clinics
    Figure 14. Product Picture of Others
    Figure 15. Global Vertebroplasty & Kyphoplasty Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Vertebroplasty & Kyphoplasty Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Vertebroplasty & Kyphoplasty Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Vertebroplasty & Kyphoplasty Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Vertebroplasty & Kyphoplasty Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Vertebroplasty & Kyphoplasty Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Vertebroplasty & Kyphoplasty Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value (%), (2019-2030)
    Figure 28. United States Vertebroplasty & Kyphoplasty Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Vertebroplasty & Kyphoplasty Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Vertebroplasty & Kyphoplasty Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Vertebroplasty & Kyphoplasty Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Vertebroplasty & Kyphoplasty Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Vertebroplasty & Kyphoplasty Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Vertebroplasty & Kyphoplasty Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2023 VS 2030
    Figure 49. Vertebroplasty & Kyphoplasty Industrial Chain
    Figure 50. Vertebroplasty & Kyphoplasty Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation

Description

Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.

The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1234 million in 2023 and is forecast to a readjusted size of US$ 1571.4 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

Global Vertebroplasty and Kyphoplasty Devices key players include Medtronic, Stryker, J&J (Depuy Synthes), Globus Medical, Merit Medical, etc. Global top five manufacturers hold a share about 85%. North America is the largest market, with a share about 55%, followed by Asia-Pacific, with a share about 25 percent. In terms of product, Kyphoplasty is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Ambulatory Surgery Center, etc.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Vertebroplasty & Kyphoplasty, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Vertebroplasty & Kyphoplasty by region & country, by Type, and by Application.

The Vertebroplasty & Kyphoplasty market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vertebroplasty & Kyphoplasty.

Market Segmentation